Homburger advised VectivBio on the deal. NKF acted as Swiss counsel to SVB Securities, Piper Sandler and LifeSci Capital in the public offering. VectivBio Holding AG (Nasdaq:...
VectivBio’s $54 Million Aggregate Financing
Kering’s Sale of Ulysse Nardin & Girard-Perregaux in a Management Buyout
Vischer advised the management of the Sowind group. Homburger advised Kering on the transaction. Kering entered into an agreement for the sale of its entire stake...
Coinbase’s Acquihire of BRD
Homburger acted as Swiss counsel to Coinbase. Coinbase (Nasdaq: COIN), a leading provider of end-to-end financial infrastructure and technology for the cryptoeconomy, announced its acquihire of BRD,...
Swiss Prime Site’s Acquisition of Akara Group
Homburger advised Swiss Prime Site AG on the deal. Niederer Kraft Frey advised the founders and shareholder of Akara Group. Swiss Prime Site AG announced the...
VectivBio’s Acquisition of Comet Therapeutics
Homburger advised VectivBio Holding AG in this matter. VectivBio Holding AG announced the acquisition of Comet Therapeutics, Inc., a biotechnology company that has been developing drugs...
Glatfelter Corp.’s DKK 2 Billion Acquisition of Jacob Holm & Sønner
Accura advised Mikkelsen family in connection with the transaction. Homburger advised Glatfelter. Shearman & Sterling advised Glatfelter. The Danish company Jacob Holm & Sønner has been...
VectivBio’s Initial Public Offering And Listing on Nasdaq
Homburger advised VectivBio, while Latham & Watkins LLP and Niederer Kraft Frey represented the underwriters on the deal. VectivBio Holding AG announced its initial public offering...